Orenitram
Active substance: treprostinil
TABLET, EXTENDED RELEASE · TREPROSTINIL .25 mg/1
United StatesActive
Marketing holder: United Therapeutics Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- TREPROSTINIL · .25 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 3 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-9b96-7b34-bb1d-2c0da887eef6,01a1208c-9b99-74e8-9e3a-b74aa28ea904,01a1208c-9b9b-7be8-bc8e-e7f66a5a1bce,01a1208c-ce89-7a52-9bec-cc93837b0316,01a1208c-e068-73f2-99c8-b4f663280d97;count=52 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 66302-302
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 66302-302 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 66302-302 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 66302-302 · Verified 2026-10-09 · open in source